Shipped cold to your door  ·  Lyophilized vialsQuestions? WhatsApp +62 811 2120 5090
A man and a woman jogging in a pine forest
Hormones

Tesamorelin and Ipamorelin: two different pathways in the growth hormone family

15 August 2026

Tesamorelin and Ipamorelin are among the names most often discussed in the growth hormone and performance group. Neither one brings in growth hormone from outside. Both send a signal to a system that already exists in the body, through different receptor doors. If you are new to the term peptide, Peptides for beginners: where to start can give you the basic context before you read the names in the catalog.

Why these two names often appear side by side

Tesamorelin and Ipamorelin are both placed in the family of discussions related to growth hormone release. The umbrella term sometimes used for this group is growth hormone secretagogue. That term helps with grouping, while the way each one works remains different and neither is a newer generation of the other.

The most useful way to read the catalog is to look at where each compound sits in the signaling chain. Some mimic the opening signal, some enter through another receptor, and some come after the chain is already running. With this framework, names that look similar are easier to tell apart.

Tesamorelin: mimicking the opening signal

Tesamorelin is a GHRH analog made more stable so that it does not break down quickly. GHRH itself is the body's natural signal that plays a role in opening growth hormone release. Because it mimics a signal the body already uses, the discussion around it relates to a release pattern that follows the body's rhythm, not to adding growth hormone from outside.

The most widely cited research on Tesamorelin looks at visceral fat, which is why that topic often appears in descriptions of the compound.

Ipamorelin: a different way in

Ipamorelin is not a GHRH derivative. This compound mimics a natural signal related to hunger and works through a different receptor. So its relationship with Tesamorelin is better seen as two parallel pathways that can both lead to growth hormone release.

Early literature notes that Ipamorelin has a relatively more focused profile than some of the older compounds in its group. This profile is what made it widely known in the research world.

What works after the signal

The same catalog group also includes IGF-1 LR3, which sits in a different position. IGF-1 is downstream, after growth hormone has done its work, so IGF-1 LR3 is not a signal opener like Tesamorelin or Ipamorelin. PEG-MGF is also in the downstream part of that chain. This simple distinction helps you see the pathway of each name within one group.

Their track record in research

Tesamorelin has already been approved in some countries for one very specific use, while Ipamorelin is widely known among researchers for its focused profile. For guidance on reading product descriptions, read A guide to reading peptide product information.

A checklist for buying peptides online safely helps you check the basic information of a product. Full details on Tesamorelin and Ipamorelin are in the Peptivia catalog. If there is anything you would like to ask before ordering, the Peptivia team is ready to help through our official WhatsApp.

Peptides in this article

Still deciding which one fits? Tell us your goal and we will help you narrow it down.

Chat on WhatsApp